SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 78.15 |
| Enterprise Value ($M) | 7.06 |
| Book Value ($M) | 71.48 |
| Book Value / Share | 0.55 |
| Price / Book | 1.09 |
| NCAV ($M) | 69.49 |
| NCAV / Share | 0.54 |
| Price / NCAV | 1.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.30 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.57 |
| Current Ratio | 14.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 74.46 |
| Assets | 76.44 |
| Liabilities | 4.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -27.62 |
| Net Income | -25.50 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.03 |
| Cash from Investing | -0.02 |
| Cash from Financing | 3.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | CVI Investments, Inc. | 4.30 | -27.05 | |
| 13G/A | Vanguard Group Inc | 5.24 | 0.00 | |
| 13G | BlackRock, Inc. | 7.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 115,113 | 391,024 | 29.44 | |
| 122,523 | 531,801 | 23.04 | |
| 357,817 | 674,566 | 53.04 | |
| 122,252 | 441,415 | 27.70 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ASRT – Assertio Holdings, Inc. | ATHA – Athira Pharma, Inc. |
| ATNF – 180 Life Sciences Corp. | ATYR – aTyr Pharma, Inc. |
| AVTX – Avalo Therapeutics, Inc. |